Genetic factors account for 40%–60% of all AMD attribution risk, and variants in CFH and ARMS2–HTRA1 confer the highest risk of AMD (Seddon, 2017; Mitchell et al., 2018). This evidence concerns the gene ARMS2 and age-related macular degeneration.